<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03379272</url>
  </required_header>
  <id_info>
    <org_study_id>n°2016-A01754-47</org_study_id>
    <nct_id>NCT03379272</nct_id>
  </id_info>
  <brief_title>Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital</brief_title>
  <acronym>CONNECT</acronym>
  <official_title>CONNECT: Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioSerenity</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pitié-Salpêtrière Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>BioSerenity</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study is designed to evaluate the performance of the Neuronaute in comparison&#xD;
      with the gold standard EEG in patients with a regular appointment at the hospital. The design&#xD;
      of this study is guided by two overriding factors : (i) epileptics disorders suspected or&#xD;
      either (ii) epileptics already diagnosed.&#xD;
&#xD;
      Volunteers will be asked to participate to this study. This study will enroll 35 outpatient&#xD;
      subjects aged 18 to 85. Informed consent will be obtained from the patients, and assent from&#xD;
      the subjects, prior to any form of assessment or intervention as part of the study.&#xD;
&#xD;
      Patients will be submitted to the studied device record Neuronaute following by the gold&#xD;
      standard EEG.&#xD;
&#xD;
      A grid with all EEG activity recorded during the trial will be provided for evaluation after&#xD;
      completion of the trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Device evolves.&#xD;
  </why_stopped>
  <start_date type="Anticipated">December 20, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reproducibility of electroencephalographic signals interpretation recorded by the Neuronaute compared to the gold standard.</measure>
    <time_frame>1 year</time_frame>
    <description>The main evaluation criteria is the reproducibility based on the interpretation of electroencephalographic signals recorded by the Neuronaute compared to the gold standard. The system will be considered effective if there are no significant differences in the physiological parameters recorded by the two systems.&#xD;
A clinical expert will interpret the EEG(electroencephalography) signals and fill the EEG evaluation sheet. It includes items such as signals quality and presence of abnormal events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Neuronaute will be considered effective if it detects inter-critical epileptic abnormalities in at least one patient.</measure>
    <time_frame>1 year</time_frame>
    <description>A section of the evaluation sheet is designed for the secondary objectives.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Neuronaute will be considered efficient if the installation time is at least as fast as the installation of the gold standard. The time will be measured from the beginning of the patient's preparation until the beginning of the recording.</measure>
    <time_frame>2 hours</time_frame>
    <description>The time needed to set up the clinical device and the device under test will be noted in the Case Report Form.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of the Neuronaute's ECG signal will be compared with the gold standard using an evaluation grid.</measure>
    <time_frame>1 year</time_frame>
    <description>An evaluation grid led to compare the quality of th Neuronaute's ECG signal and Gold Standard' signal</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>GOLD STANDARD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RECORDING WITH EEG GOLD STANDARD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NEURONAUTE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RECORDING WITH THE NEURONAUTE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GOLDSTANDARD</intervention_name>
    <description>RECORDING WITH EEG GOLDSTANDARD</description>
    <arm_group_label>GOLD STANDARD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NEURONAUTE</intervention_name>
    <description>RECORDING WITH NEURONAUTE</description>
    <arm_group_label>NEURONAUTE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients, with a regular appointment to perform an EEG recording: (i) suspected of&#xD;
             epileptic disorders or (ii) epilepsy already diagnosed.&#xD;
&#xD;
          -  Age (&gt; 18 years),&#xD;
&#xD;
          -  Affiliated to the social security&#xD;
&#xD;
          -  Informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No informed consent&#xD;
&#xD;
          -  Age (&lt; 18 years)&#xD;
&#xD;
          -  No affiliation to the social security&#xD;
&#xD;
          -  Unsuitable anthropometric parameters&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Recent brain surgery&#xD;
&#xD;
          -  Wound or scores on the body and the scalp&#xD;
&#xD;
          -  Ongoing participation in another clinical trial&#xD;
&#xD;
          -  Allergy to any component from MD including : Silver, polyamide, silicone&#xD;
&#xD;
          -  Sensory disorders making the patient insensitive to pain on the skin&#xD;
&#xD;
          -  Behavioral disorders making the patient excessively agitated or aggressive;&#xD;
&#xD;
          -  Motor or mental disorders preventing the patient from expressing his or her pain;&#xD;
&#xD;
          -  Cardiorespiratory disorders likely to be aggravated by slight compression of the&#xD;
             chest;&#xD;
&#xD;
          -  The susceptibility to tension headaches (the compression exerted by the bonnet may in&#xD;
             certain cases trigger a headache)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 7, 2016</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electroencephalography</keyword>
  <keyword>Epilepsy</keyword>
  <keyword>EEG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

